Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 8/20 | 0.53 |
| ▸ | HTR1A known ✓ | P08908 | 2/20 | 0.53 |
| ▸ | ADRA2A known ✓ | P08913 | 2/20 | 0.53 |
| ▸ | ADRA2C known ✓ | P18825 | 2/20 | 0.53 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.53 |
| ▸ | ADRA1A known ✓ | P35348 | 2/20 | 0.53 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.53 |
| ▸ | HTR2B known ✓ | P41595 | 2/20 | 0.53 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.53 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.53 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.53 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.53 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.53 |
| ▸ | ADRA1B known ✓ | P35368 | 1/20 | 0.53 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 8/20 | 0.53 |
| ▸ | DRD3 | P35462 | 8/20 | 0.53 |
| ▸ | HTR7 | P34969 | 2/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27545654 | 0.91 | DRD2 (0.62) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7775336 | 0.90 | DRD2 (0.52) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7775401 | 0.87 | DRD2 (0.54) | DRD2DRD4DRD3HTR1AHTR7 | |
| Fumaric Acid SCHEMBL7776886 | 0.83 | DRD2 (0.42) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7776847 | 0.83 | DRD2 (0.42) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7775438 | 0.80 | DRD2 (0.57) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7773337 | 0.80 | MAPT (0.48) | DRD2DRD4DRD3HTR1AHTR7 | |
| SCHEMBL7773419 | 0.80 | DRD2 (0.61) | DRD2DRD4DRD3HTR1AADRA2A | |
| Fumaric Acid SCHEMBL7775337 | 0.80 | ALDH1A1 (0.52) | DRD2DRD4DRD3HTR1AADRA2A | |
| SCHEMBL7773438 | 0.79 | DRD4 (0.51) | DRD2DRD4DRD3HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000018767-A9 | 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORP (US) | 2001-04-19 | — | — | WO | claimed |
| EP-1117663-A2 | 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018767-A9 | 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORP (US) | 2001-04-19 | — | — | WO | disclosed |
| WO-2000018767-A2 | 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 2000-04-06 | — | — | WO | disclosed |